Covered recipient · General Payments record
KIMBERLY FREITAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,878.78
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $373.61 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $143.33 | 4 |
| ABBVIE INC. | $73.52 | 4 |
| Biogen, Inc. | $47.47 | 2 |
| Sumitomo Pharma America, Inc. | $31.83 | 2 |
| PFIZER INC. | $22.34 | 1 |
| Amgen Inc. | $21.25 | 1 |
| Organon LLC | $19.31 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.28 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107131998 | CMS |
| ABBVIE INC. | $15.58 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107132000 | CMS |
| ABBVIE INC. | $17.74 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107132002 | CMS |
| ABBVIE INC. | $16.92 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107132004 | CMS |
| Amgen Inc. | $21.25 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117254668 | CMS |
| Astellas Pharma US Inc | $19.35 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139495180 | CMS |
| Astellas Pharma US Inc | $15.66 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139515957 | CMS |
| Astellas Pharma US Inc | $102.91 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139545539 | CMS |
| Astellas Pharma US Inc | $5.41 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139557093 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.56 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086312313 | CMS |
| Biogen, Inc. | $20.17 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104861916 | CMS |
| Biogen, Inc. | $27.30 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104857240 | CMS |
| Organon Llc | $19.31 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136238944 | CMS |
| PFIZER INC. | $22.34 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131178877 | CMS |
| Sumitomo Pharma America, Inc. | $14.59 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148960728 | CMS |
| Sumitomo Pharma America, Inc. | $17.24 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148960730 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.